USD 7.57
(5.73%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -360.25 Million USD | 31.21% |
2022 | -523.7 Million USD | 28.24% |
2021 | -729.8 Million USD | 21.86% |
2020 | -933.96 Million USD | -651.52% |
2019 | -124.27 Million USD | -159.05% |
2018 | -47.97 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q3 | -235.54 Million USD | 11.75% |
2024 Q1 | -297.7 Million USD | 17.36% |
2024 Q2 | -266.92 Million USD | 10.34% |
2023 Q1 | -99.02 Million USD | 81.09% |
2023 FY | -360.25 Million USD | 31.21% |
2023 Q4 | -360.25 Million USD | -17.39% |
2023 Q3 | -306.88 Million USD | -106.76% |
2023 Q2 | -148.42 Million USD | -49.89% |
2022 Q2 | -241.17 Million USD | -50.21% |
2022 Q1 | -160.55 Million USD | 78.0% |
2022 FY | -523.7 Million USD | 28.24% |
2022 Q4 | -523.7 Million USD | -65.33% |
2022 Q3 | -316.77 Million USD | -31.35% |
2021 FY | -729.8 Million USD | 21.86% |
2021 Q4 | -729.8 Million USD | 5.5% |
2021 Q3 | -772.29 Million USD | 20.46% |
2021 Q2 | -970.94 Million USD | -9.04% |
2021 Q1 | -890.48 Million USD | 4.66% |
2020 Q1 | -118.18 Million USD | 4.9% |
2020 Q4 | -933.96 Million USD | 1.38% |
2020 Q3 | -947.04 Million USD | -325.65% |
2020 Q2 | -222.49 Million USD | -88.26% |
2020 FY | -933.96 Million USD | -651.52% |
2019 FY | -124.27 Million USD | -159.05% |
2019 Q4 | -124.27 Million USD | 0.0% |
2018 FY | -47.97 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Doximity, Inc. | -82.23 Million USD | -338.055% |
Evolent Health, Inc. | 451.97 Million USD | 179.707% |
MultiPlan Corporation | 4.48 Billion USD | 108.03% |
Phreesia, Inc. | -75.53 Million USD | -376.921% |
Teladoc Health, Inc. | 468.6 Million USD | 176.878% |
Veeva Systems Inc. | -647.71 Million USD | 44.381% |